<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Immunocellular Therapeutics Ltd — News on 6ix</title>
    <link>https://6ix.com/company/immunocellular-therapeutics-ltd</link>
    <description>Latest news and press releases for Immunocellular Therapeutics Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 07 Nov 2023 12:01:40 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/immunocellular-therapeutics-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683583a378dffbe2df0fcc77.webp</url>
      <title>Immunocellular Therapeutics Ltd</title>
      <link>https://6ix.com/company/immunocellular-therapeutics-ltd</link>
    </image>
    <item>
      <title>EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613</title>
      <link>https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceutical-holdings-provides-an-update-on-its-lead-drug-candidate-eom613</link>
      <guid isPermaLink="true">https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceutical-holdings-provides-an-update-on-its-lead-drug-candidate-eom613</guid>
      <pubDate>Tue, 07 Nov 2023 12:01:40 GMT</pubDate>
      <description>EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613.</description>
    </item>
    <item>
      <title>EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil</title>
      <link>https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceutical-holdings-announces-topline-results-of-its-covid-19-clinical-trial-of-eom613-in-brazil</link>
      <guid isPermaLink="true">https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceutical-holdings-announces-topline-results-of-its-covid-19-clinical-trial-of-eom613-in-brazil</guid>
      <pubDate>Wed, 06 Sep 2023 11:02:26 GMT</pubDate>
      <description>EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil.</description>
    </item>
    <item>
      <title>Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors</title>
      <link>https://6ix.com/company/immunocellular-therapeutics-ltd/news/codexis-announces-appointment-of-rahul-singhvi-scd-to-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/immunocellular-therapeutics-ltd/news/codexis-announces-appointment-of-rahul-singhvi-scd-to-board-of-directors</guid>
      <pubDate>Mon, 03 Oct 2022 12:01:22 GMT</pubDate>
      <description>Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors.</description>
    </item>
    <item>
      <title>EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement</title>
      <link>https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceuticals-inc-and-immunocellular-therapeutics-ltd-announce-entry-into-and-close-of-definitive-merger-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/immunocellular-therapeutics-ltd/news/eom-pharmaceuticals-inc-and-immunocellular-therapeutics-ltd-announce-entry-into-and-close-of-definitive-merger-agreement</guid>
      <pubDate>Thu, 02 Dec 2021 13:01:59 GMT</pubDate>
      <description>EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement.</description>
    </item>
  </channel>
</rss>